Effects of antibody reactivity to major histocompatibility complex (MHC) and non-MHC alloantigens on graft endothelial cells in heart allograft rejection

Transplantation

Volumn 69, Issue 9, 2000, Pages 1899-1906

  Derhaag, Josien G ^a   Duijvestijn, Adrian M ^a   Damoiseaux, Jan G M C ^a   Van Breda Vriesman, Peter J C ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIBODY; ALLOANTIGEN; CELL ADHESION MOLECULE; CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN SUBCLASS; INTERCELLULAR ADHESION MOLECULE 1; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIGEN EXPRESSION; ARTICLE; COMPLEMENT ACTIVATION; COMPLEMENT DEPENDENT CYTOTOXICITY; CONTROLLED STUDY; ENDOTHELIUM CELL; GRAFT REJECTION; HEART TRANSPLANTATION; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RAT; VASCULAR DISEASE;

EID: 0034658671     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200005150-00027     Document Type: Article

References (38)

1. Colvin RB. Cellular and molecular mechanism of allograft rejection. Annu Rev Med 1990; 41: 361.
2. Colson YL, Markus BH, Zeevi A, Duquesnoy RJ. Interactions between endothelial cells and alloreactive T cells involved in allograft immunity. Transplant Proc 1988; 20: 47.
3. Russell PS, Chase CM, Winn HJ, Colvin RB. Coronary atherosclerosis in transplanted mouse hearts. J Immunol 1994; 152: 5135.
4. Tixier D, Tuso P, Czer L, et al. Characterization of anti-endothelial cell and anti-heart antibodies following heart transplantation. Transplant Proc 1993; 25: 931.
5. Moller E. Cell interactions and cytokines in transplantation immunity. Transplant Proc 1995; 27: 24.
6. Lowry RP, Gurley KE, Forbes RDC. Immune mechanisms in organ allograft rejection. Transplantation 1983; 36: 391.
7. Bolton EM, Gracie JA, Briggs JD, Kampinga J, Bradley JA. Cellular requirements for renal allograft rejection in the athymic nude rat. J Exp Med 1989; 169: 1931.
8. Saadi S, Platt J. Transient pertubation of endothelial integrity induced by natural antibodies and complement. J Exp Med 1995; 181: 21.
9. Bevilaqua MP, Pober JS, Majeau GR, Cotran RS, Gimbrone MAJ. Interleukin 1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells. J Exp Med 1984; 160: 618.
10. Saadi S, Holzknecht RA, Patte CP, Stern DM, Platt JL. Complement mediated regulation of tissue factor activity in endothelium. J Exp Med 1995; 182: 1807.
11. Camussi G, Bussolino F, Salvidio G, Baglioni C. Tumor necrosis factor/cachetin stimulates peritoneal macrophages, polymorphonuclear neutrophils, and vascular endothelial cells to synthesize and release platelet-activating factor. J Exp Med 1987; 166: 1390.
12. Vaporciyan AA, Mulligan MS, Warren JS, Barton PA, Miyasaka M, Ward PA. Up-regulation of lung vascular ICAM-1 in rats is complement dependent. J Immunol 1995; 155: 1442.
13. Kilgore KS, Shen JP, Miller BF, Ward PA, Warren JS. Enhancement by the complement membrane attack complex of tumor necrosis factor-induced endothelial cell expression of E-selectin and ICAM-1. J Immunol 1995; 155: 1434.
14. Carvalho D, Savage COS, Black CM, Pearson JD. IgG anti-endothelial cell autoantibodies from scleroderma patients induce leucocyte adhesion to human vascular endothelial cells in vitro. J Clin Invest 1996; 97: 111.
15. Brauer RB, Baldwin WM III, Ibrahim S, Sanfilippo F. The contribution of the terminal complement components to acute and hyperacute allograft rejection in the rat. Transplantation 1995; 59: 288.
16. Yard B, Spruyt-Gerritse M, Claas F, et al. The clinical significance of allospecific antibodies against endothelial cells detected with an antibody-dependent cellular cytotoxicity assay for vascular rejection and graft loss after renal transplantation. Transplantation 1993; 55: 1287.
17. Bradley JA, Mowat AM, Bolton EM. Processed MHC class I alloantigen as the stimulus for CD4+ T-cell dependent antibody-mediated graft rejection. Immunol Today 1992; 13: 434.
18. Adams H, Tilney NL, Collins JJ, Karnovsky MJ. Experimental graft arteriosclerosis. Transplantation 1992; 53: 1115.
19. Dunn MJ, Crisp SJ, Rose ML, Taylor PM, Yacoub MH. Anti-endothelial antibodies and coronary artery disease after cardiac transplantation. Lancet 1992; 339: 1566.
20. Crisp SJ, Dunn MJ, Rose ML, Barbir M, Yacoub MH. Anti-endothelial antibodies after heart transplantation: the accelerating factor in transplant-associated coronary artery disease. J Heart Lung Transplant 1994; 13: 81.
21. Derhaag J, Duijvestijn A, Emeis J, Engels W, van Breda Vriesman PJC. Production and characterization of spontaneous rat-heart endothelial cell lines. Lab Invest 1996; 74: 437.
22. Derhaag JG, Duijvestijn AM, van Breda Vriesman PJC. Heart EC respond heterogeneous on cytokine stimulation in ICAM-1 and VCAM-1, but not in MHC expression; a study with 3 rat heart endothelial cell (RHEC) lines. Endothelium 1997; 5: 307.
23. van Schilfgaarde R, Hermans P, Terpstra JL, van Breda Vriesman PJC. Role of mobile passenger lymphocytes in the rejection of renal and cardiac allografts in the rat: a passenger lymphocyte mediated graft versus host reaction amplifies the host response. Transplantation 1980; 29: 209.
24. Derhaag JG, Duijvestijn AM, Damoiseaux JGMC, van Breda Vriesman PJC. An in vitro model for studying the role of graft endothelial cells in rat heart allograft rejection: a study on the regulation and function of heart endothelial histocompatibility antigens and cell adhesion molecules. Transplant Proc 1997; 29: 1717.
25. Maciag T, Cerendulo J, Isley S, Kellu PR, Forand R. An endothelial growth factor from bovine hypothalamus: identification and partial characterization. Proc Natl Acad Sci USA 1979; 76: 5674.
26. Poncelet PG, Lavabre-Bertrand T. Immunological detection of membrane-bound antigens and receptors. Methods Immunol Anal 1993; 388.
27. Duijvestijn AM, van Goor H, Klatter F, Majoor GD, van Bussel E, van Breda Vriesman PJC. Antibodies defining rat endothelial cells: RECA-1, a pan endothelial specific monoclonal antibody. Lab Invest 1992; 62: 459.
28. Tamatani T, Miyasaka M. Identification of monoclonal antibodies reactive with the rat homolog of ICAM-1 and evidence for a differential involvement of ICAM-1 in the adherence of resting versus activated lymphocytes to high endothelial cells. Int Immunol 1990; 2: 165.
29. May MJ, Entwistle G, Humphries MJ, Ager A. VCAM-1 is a CS-1 peptide-inhibitable adhesion molecule expressed by lymph node high endothelium. J Cell Sci 1993; 106: 109.
30. Ferry BL, Welsh KI, Dunn MJ, et al. Anti-cell surface endothelial antibodies in sera from cardiac and kidney transplant recipients. Transplant Immunol 1997; 5(1): 17.
31. Orosz CG. Endothelial activation and chronic allograft rejection. Clin Transplant 1994; 8: 299.
32. Sekhavat M, Ravoet AM, Neirynck A, Sokal G. Rat monoclonal antibodies for complement mediated and cell mediated cytolysis. In: Bazin H (ed.). Rat hybridomas and rat monoclonal antibodies 1999. CRC Press, Boca Raton. Pp 446-454.
33. Gilks WR, Gore SM, Bradley BA. Renal transplant rejection: transient immunodominance of HLA mismatches. Transplantation 1990; 50: 141.
34. Duijvestijn A, Vlek L, Duistermaat L, van Rie H, van Breda Vriesman P. Chronic renal allograft rejection: the significance of non-MHC alloantigens. Transplantation Int 1992; 5, Suppl 1: s639.
35. Joyce S, Flye MW, Mohanakumar T. Characterization of kidney cell-specific, non-major histocompatibility complex alloantigen using antibodies from rejected human renal allografts. Transplantation 1988; 46: 362.
36. Briscoe DM, Schoen FJ, Rice GE, Bevilaqua MP, Ganz P, Pober P. Induced expression of endothelial-leucocyte adhesion molecules in human cardiac allografts. Transplantation 1991; 51: 537.
37. Pelletier RP, Morgan CJ, Sedmak DD, et al. Analysis of inflammatory endothelial changes, including VCAM-1 expression, in murine cardiac grafts. Transplantation 1993; 55: 315.
38. van der Woude FJ, Deckers JG, Mallat MJ, et al. Tissue antigens in tubulointerstitial and vascular rejection. Kidney Int 1995; 53: 1119.